This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Gilead Sciences, Inc., Janssen Sciences Ireland Uc. Active years: 2020.
Company Filing History:
1 out of 946 
1 out of 111 
Years Active: 2020
Title: The Innovative Contributions of Regina Driesen
Introduction
Regina Driesen is a notable inventor based in Kessel, Belgium. She has made significant contributions to the field of medicine, particularly in the treatment of HIV. Her innovative work has led to the development of effective methods that enhance the quality of life for those affected by this virus.
Latest Patents
Regina holds a patent for "Compositions and methods of treating HIV." This patent focuses on methods of treating subjects infected with HIV using a once-daily regimen. The treatment involves single unit dosage forms that include darunavir, cobicistat, emtricitabine, and a tenofovir prodrug or its salt. This advancement represents a crucial step in HIV therapy, providing patients with a more manageable treatment option.
Career Highlights
Throughout her career, Regina has worked with prominent companies in the pharmaceutical industry. She has been associated with Janssen Sciences Ireland and Gilead Sciences, Inc. These experiences have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Regina has worked alongside esteemed colleagues, including Goedele De Smedt and Vahid Zia. Their combined expertise has fostered an environment of innovation and progress in HIV treatment methodologies.
Conclusion
Regina Driesen's contributions to the field of HIV treatment exemplify her dedication to improving patient outcomes. Her innovative patent and collaborations with industry leaders highlight her role as a significant figure in medical research.